Optimal type and dose of exercise to improve glycated haemoglobin in individuals with type 1 diabetes: A systematic review and Bayesian dose–response network meta‐analysis of RCTs
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.70115 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Yifan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Physical Education, Myongji University, Yongin, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Glycated Hemoglobin, Exercise, Exercise Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
High levels of glycated haemoglobin (HbA1c) in people with type 1 diabetes (T1D) are associated with high mortality and cardiovascular risk. Physical activity is an affordable intervention that is available to most people, but the type and amount of exercise to induce metabolic benefits in T1D are not known with certainty.
Objective
To determine the comparative effectiveness of diverse exercise modes and dosages to influence HbA1c in patients with T1D.
Methods
The process involved systematically searching PubMed, Web of Science, Embase and The Cochrane Library databases; no limits were imposed on date or language of publication. Bayesian network and dose–response meta‐analyses based on a random‐effects model were carried out to assess the impact of exercise on the HbA1c levels.
Results
Nineteen studies were included in the systematic review. Only multi‐component exercise (ME) significantly reduced HbA1c (−0.81%, 95% CrI: −1.33 to −0.34; SUCRA: 93.75%; low‐quality evidence). High‐intensity interval training (−0.38%, 95% CrI: −1.16 to 0.39; SUCRA: 51.52%) and aerobic exercise (−0.31%, 95% CrI: −0.74 to 0.16; SUCRA: 47.01%) showed no significant benefit. For ME, an L‐shaped non‐linear dose–response was observed, with statistical significance at 52 metabolic equivalent of task (MET‐min/week) and the minimal clinically important difference (MCID; ≥ 0.5% reduction) achieved at 160 MET‐min/week (−0.52%, 95% CrI: −0.89 to −0.13). The greatest reduction occurred at 1500 MET‐min/week (−0.82%, 95% CrI: −1.31 to −0.27).
Conclusions
A dose of ME necessary to achieve MCID (e.g., 10 min of running and curl‐ups, three times per week) was well below the American Diabetes Association's minimum recommendation. For adolescents, we recommend combining aerobic and resistance training, performed for at least 12 weeks with 160 to 1200 MET‐min/week (equivalent to 25–220 min per week), to balance effectiveness and minimise exercise burden. The high‐quality randomized controlled trials of this dose range are required to confirm efficacy and evaluate safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Physical Education, Myongji University, Yongin, Republic of Korea.
- College of Humanities and Physical Education, Hebei Oriental University, Langfang, Hebei Province, China.
- Jiangsu College of Nursing, Huai'an City, Jiangsu Province, China.
ORCID-Profile: Yifan Zhang, Jingyi Zhou
Zitieren
APA
Zhang, Y., Zhou, J., Chen, X., Huang, H., Fan, Z., & Wang, Z. (2025). Optimal type and dose of exercise to improve glycated haemoglobin in individuals with type 1 diabetes: A systematic review and Bayesian dose–response network meta‐analysis of RCTs. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70115
Vancouver
Zhang Y, Zhou J, Chen X, Huang H, Fan Z, Wang Z. Optimal type and dose of exercise to improve glycated haemoglobin in individuals with type 1 diabetes: A systematic review and Bayesian dose–response network meta‐analysis of RCTs. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.70115
BibTeX
@article{Zhang2025,
author = {Zhang, Yifan and Zhou, Jingyi and Chen, Xueying and Huang, Hao and Fan, Zhixin and Wang, Zhibo},
title = {Optimal type and dose of exercise to improve glycated haemoglobin in individuals with type 1 diabetes: A systematic review and Bayesian dose–response network meta‐analysis of RCTs},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.70115}
}
EUVIMED